Jeff Yass’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Jeff Yass’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-26,300	Closed	-$2.56M	–	10811
2015 Q1	$2.56M	Sell	26,300 -2,500	-9%	-$265K	﹤0.01%	3830
2014 Q4	$2.67M	Sell	28,800 -27,400	-49%	-$2.16M	﹤0.01%	3925
2014 Q3	$3.87M	Sell	56,200 -130,200	-70%	-$9.32M	﹤0.01%	3429
2014 Q2	$19.5M	Buy	186,400 +58,900	+46%	+$5.01M	0.01%	1426
2014 Q1	$10.6M	Buy	127,500 +106,200	+499%	+$9.82M	﹤0.01%	1954
2013 Q4	$1.38M	Sell	21,300 -20,400	-49%	-$1.21M	﹤0.01%	4921
2013 Q3	$2.64M	Buy	+41,700	New	+$2.05M	﹤0.01%	3672

Jeff Yass's GEVA Position: Q2 2015 in Review

Jeff Yass sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 6,944 shares — an estimated $677K sold.

Jeff Yass first reported a position in GEVA in Q2 2013 and held it in 8 quarters. The position peaked at $1.9M in Q4 2013. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Jeff Yass reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Jeff Yass sold 6,944 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $677K.
Jeff Yass first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
Jeff Yass's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.9M in Q4 2013.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Susquehanna International Group's 13F filing for Q2 2015, filed 14 Aug 2015.